View:
United States securities and exchange commission logo
April 2, 2021
Lisa Walters-Hoffert
Chief Financial Officer
Dar Bioscience, Inc.
3655 Nobel Drive, Suite 260
San Diego, CA 92122
Re: Dar Bioscience,
Inc.
Registration
Statement on Form S-3
Filed March 30,
2021
File No. 333-254862
Dear Ms. Walters-Hoffert:
This is to advise you that we have not reviewed and will not
review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for
acceleration. We remind you
that the company and its management are responsible for the accuracy and
adequacy of their
disclosures, notwithstanding any review, comments, action or absence of
action by the staff.
Please contact Jane
Park at 202-551-7439 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Scott Stanton